M Gent

发表

1. Design and main results of the trial.

H J Barnett, M Gent, D L Sackett, 1980, Canadian Medical Association journal.

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high‐risk abdominal surgery

M Gent, D Bergqvist, M. Gent, 2005, The British journal of surgery.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

M Gent, B. O'brien, S. Connolly, 2000, Circulation.

Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

M Gent, J Bormanis, J. Hirsh, 2000, Thrombosis and Haemostasis.

Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction.

M Gent, B J Sealey, J. Cairns, 1996, The New England journal of medicine.

Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study

M Gent, R Goeree, B. O'brien, 2001, Circulation.

Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

M Gent, A Laupacis, A. Laupacis, 1991, Journal of the American College of Cardiology.

An alternative to the use of two-sided tests in clinical trials.

M Gent, C. Dunnett, M. Gent, 1996, Statistics in medicine.

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.

M Gent, P. Armstrong, M. Gent, 1989, Journal of the American College of Cardiology.

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

M Gent, M H Prins, H R Büller, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

M Gent, S. Connolly, M. Gent, 1993, The American journal of cardiology.

Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.

M Gent, M H Prins, H R Büller, 2003, The New England journal of medicine.

Prevention and treatment of postphlebitic syndrome: results of a 3-part study.

M Gent, M. Gent, J. Julian, 2001, Archives of internal medicine.

Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: Results From the Canadian Implantable Defibrillator Study (CIDS)

M Gent, R Goeree, R Yee, 2001, Circulation.

Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes

M Gent, S. Yusuf, S. Connolly, 2000 .

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

M Gent, J. Hirsh, M. Gent, 1999, The New England journal of medicine.

Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.

M Gent, E Genton, D. Sackett, 1979, The New England journal of medicine.

How should results from completed studies influence ongoing clinical trials? The CAFA Study experience.

M Gent, A Laupacis, A. Laupacis, 1991, Annals of internal medicine.

Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism

M Gent, J Bormanis, J. Hirsh, 1998, Annals of Internal Medicine.

Diagnosis of Venous Thrombosis

M Gent, Aken, J. Hirsh, 2005 .